Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases.
Gabelli M, Stepensky P, Ottaviano G, Mullanfiroze K, Lazareva A, Zaidman I, Even-Or E, Lucchini G, Chiesa R, Silva J, Adams S, Kricke S, Finch M, Hill A, Mead R, Veys D, Schejter YD, Eddin AN, Worth A, Amrolia PJ, Rao K. Gabelli M, et al. Among authors: lazareva a. Bone Marrow Transplant. 2023 Jan;58(1):109-111. doi: 10.1038/s41409-022-01844-x. Epub 2022 Oct 19. Bone Marrow Transplant. 2023. PMID: 36261706 No abstract available.
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Ghorashian S, Kramer AM, Onuoha S, Wright G, Bartram J, Richardson R, Albon SJ, Casanovas-Company J, Castro F, Popova B, Villanueva K, Yeung J, Vetharoy W, Guvenel A, Wawrzyniecka PA, Mekkaoui L, Cheung GW, Pinner D, Chu J, Lucchini G, Silva J, Ciocarlie O, Lazareva A, Inglott S, Gilmour KC, Ahsan G, Ferrari M, Manzoor S, Champion K, Brooks T, Lopes A, Hackshaw A, Farzaneh F, Chiesa R, Rao K, Bonney D, Samarasinghe S, Goulden N, Vora A, Veys P, Hough R, Wynn R, Pule MA, Amrolia PJ. Ghorashian S, et al. Among authors: lazareva a. Nat Med. 2019 Sep;25(9):1408-1414. doi: 10.1038/s41591-019-0549-5. Epub 2019 Sep 2. Nat Med. 2019. PMID: 31477906 Clinical Trial.
Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial.
Chiesa R, Standing JF, Winter R, Nademi Z, Chu J, Pinner D, Kloprogge F, McLellen S, Amrolia PJ, Rao K, Lucchini G, Silva J, Ciocarlie O, Lazareva A, Gennery AR, Doncheva B, Cant AJ, Hambleton S, Flood T, Rogerson E, Devine K, Prunty H, Heales S, Veys P, Slatter M. Chiesa R, et al. Among authors: lazareva a. Clin Pharmacol Ther. 2020 Aug;108(2):264-273. doi: 10.1002/cpt.1715. Epub 2019 Dec 14. Clin Pharmacol Ther. 2020. PMID: 31701524 Free PMC article. Clinical Trial.
Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.
Gabelli M, Marks DI, Sharplin K, Lazareva A, Mullanfiroze K, Farish S, Burridge S, Velangi M, Rampling D, Mozayani B, Chiesa R, Lucchini G, Samarasinghe S, Bartram J, Ghorashian S. Gabelli M, et al. Among authors: lazareva a. Br J Haematol. 2021 Dec;195(5):805-811. doi: 10.1111/bjh.17737. Epub 2021 Jul 28. Br J Haematol. 2021. PMID: 34322864 No abstract available.
Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV.
Venturini C, Houldcroft CJ, Lazareva A, Wegner F, Morfopoulou S, Amrolia PJ, Golwala Z, Rao A, Marks SD, Simmonds J, Yoshikawa T, Farrell PJ, Cohen JI, Worth AJ, Breuer J. Venturini C, et al. Among authors: lazareva a. Br J Haematol. 2021 Oct;195(2):249-255. doi: 10.1111/bjh.17790. Epub 2021 Aug 24. Br J Haematol. 2021. PMID: 34431085 Free PMC article.
CD34+-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy.
Mullanfiroze K, Lazareva A, Chu J, Williams L, Burridge S, Silva J, Chiesa R, Rao K, Lucchini G, Ghorashian S, O'Reilly M, Carpenter B, Grandage V, Hough R, Roddie C, Amrolia PJ. Mullanfiroze K, et al. Among authors: lazareva a. Blood Adv. 2022 Aug 23;6(16):4715-4718. doi: 10.1182/bloodadvances.2022007572. Blood Adv. 2022. PMID: 35790110 Free PMC article. No abstract available.
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia.
Chiesa R, Georgiadis C, Syed F, Zhan H, Etuk A, Gkazi SA, Preece R, Ottaviano G, Braybrook T, Chu J, Kubat A, Adams S, Thomas R, Gilmour K, O'Connor D, Vora A, Qasim W; Base-Edited CAR T Group. Chiesa R, et al. N Engl J Med. 2023 Sep 7;389(10):899-910. doi: 10.1056/NEJMoa2300709. Epub 2023 Jun 14. N Engl J Med. 2023. PMID: 37314354 Clinical Trial.
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.
Ghorashian S, Lucchini G, Richardson R, Nguyen K, Terris C, Guvenel A, Oporto-Espuelas M, Yeung J, Pinner D, Chu J, Williams L, Ko KY, Walding C, Watts K, Inglott S, Thomas R, Connor C, Adams S, Gravett E, Gilmour K, Lal A, Kunaseelan S, Popova B, Lopes A, Ngai Y, Hackshaw A, Kokalaki E, Carulla MB, Mullanfiroze K, Lazareva A, Pavasovic V, Rao A, Bartram J, Vora A, Chiesa R, Silva J, Rao K, Bonney D, Wynn R, Pule M, Hough R, Amrolia PJ. Ghorashian S, et al. Among authors: lazareva a. Blood. 2024 Jan 11;143(2):118-123. doi: 10.1182/blood.2023020621. Blood. 2024. PMID: 37647647
86 results